Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how B cell subsets and autoantibodies are related
to disease remission after rituximab treatment in subjects with Systemic Lupus Erythematosus
(SLE).
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)